The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and clinical activity of durvalumab monotherapy in patients with hepatocellular carcinoma (HCC).
 
Zev A. Wainberg
Consulting or Advisory Role - Amgen; Array BioPharma; Five Prime Therapeutics; Sirtex Medical
Speakers' Bureau - Genentech
Research Funding - Biomarin (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Amgen; Genentech
 
Neil Howard Segal
Honoraria - MedImmune
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Calithera Biosciences; Imugene; Kyocera; Macrogenics; Pfizer; Roche/Genentech
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Pfizer; Roche/Genentech
 
Dirk Jaeger
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Roche
 
Kyung-Hun Lee
Consulting or Advisory Role - Novartis
Research Funding - AstraZeneca
 
John Marshall
Honoraria - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Bayer/Onyx; Genentech/Roche
Research Funding - Amgen (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); MedImmune (Inst); Pfizer (Inst)
 
Scott Joseph Antonia
Stock and Other Ownership Interests - Cellular Biomedicine Group
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
 
Marcus Butler
Honoraria - Bristol-Myers Squibb; Merck; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis
 
Rachel E. Sanborn
Honoraria - AstraZeneca
Consulting or Advisory Role - Amgen; ARIAD; Genentech/Roche; Peregrine Pharmaceuticals; Seagen
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck
Travel, Accommodations, Expenses - Five Prime Therapeutics
 
John J. Nemunaitis
Employment - Gradalis
Leadership - Gradalis
Stock and Other Ownership Interests - Gradalis
Honoraria - Amgen; AstraZeneca
Consulting or Advisory Role - Amgen; AstraZeneca
Speakers' Bureau - Amgen; AstraZeneca
Patents, Royalties, Other Intellectual Property - Gradalis
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Baxalta; Takeda
 
Cheryl Ann Carlson
No Relationships to Disclose
 
Richard S. Finn
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck; Novartis; Pfizer
Research Funding - Pfizer (Inst)
 
Xiaoping Jin
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
 
Joyce Antal
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
 
Ashok Kumar Gupta
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb
 
Christophe Massard
Consulting or Advisory Role - AstraZeneca